FDA Approved: BUPRENORPHINE TRANSDERMAL SYSTEM — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for the buprenorphine transdermal system from Alvogen Inc., under the ANDA program. This action typically updates regula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE TRANSDERMAL SYSTEM (BUPRENORPHINE)